key: cord-1043122-a0srj6m6
authors: Nassar, Amer H.; Maselli, Amy M.; Dowlatshahi, A. Samandar
title: Microvascular Free Tissue Transfer in the Setting of COVID-19 Associated Coagulopathy: A Case report
date: 2021-02-23
journal: nan
DOI: 10.1016/j.orthop.2021.02.002
sha: 113f3efcef955417a7bd3ea079e4e1939c14fd8b
doc_id: 1043122
cord_uid: a0srj6m6

In the era of this pandemic, the use of free flaps for elective reconstruction should proceed with caution in the COVID-19 positive patient given the associated coagulopathy. In those who require free tissue transfer in an urgent or non-elective manner, it is advisable to consider systemic anticoagulation with an associated hematologic consultation given the theoretic higher risk of flap vascular complication. We present a case report of a young healthy and otherwise asymptomatic COVID-19 positive patient whose associated coagulopathy resulted in free flap loss and need for further operations.

In the era of this pandemic, the use of free flaps for elective reconstruction should proceed with caution in the COVID-19 positive patient given the associated coagulopathy. In those who require free tissue transfer in an urgent or non-elective manner, it is advisable to consider systemic anticoagulation with an associated hematologic consultation given the theoretic higher risk of flap vascular complication.

We present a case report of a young healthy and otherwise asymptomatic COVID-19 positive Introduction 1

In December 2019, as the novel coronavirus COVID-19 (SARS-CoV-2) began to spread across the 2 globe, accounts surfaced of a Covid-19 -associated coagulopathy (CAC). 1 While the 3 pathophysiology remains poorly understood, viral infection triggers a hypercoagulable state in 4 certain individuals, with autopsy findings notable for deep vein thrombosis in 58% and 5 pulmonary emboli in 33% of patients. 2 6 7 In the absence of long-term data regarding CAC, it remains unclear whether free tissue transfer 8 can be safely performed in patients with COVID-19 infection. We describe our recent 9 experience with a COVID-19 positive patient who underwent free flap reconstruction of both 10 lower extremities. Our case report is compliant with the SCARE guidelines. 3 

The unique characteristics of COVID-19 coagulopathy

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

The SCARE Statement: Consensus-based surgical case report guidelines

Coagulation abnormalities and thrombosis in patients with COVID-19

Clinical Characteristics of Coronavirus Disease 2019 in China

Type 3 hypersensitivity in COVID-19 vasculitis

Failure of Free Flaps in Head and Neck Oncology Surgery in COVID-19 Patients

Reconstructive Microsurgery Emergency in a Patient with Covid-19

Vascular resistance considerations in free-tissue transfer

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy